188 related articles for article (PubMed ID: 36172576)
1. Worldwide long-term trends in the incidence of nonalcoholic fatty liver disease during 1990-2019: A joinpoint and age-period-cohort analysis.
Wu W; Feng A; Ma W; Li D; Zheng S; Xu F; Han D; Lyu J
Front Cardiovasc Med; 2022; 9():891963. PubMed ID: 36172576
[TBL] [Abstract][Full Text] [Related]
2. Trends in the diabetes incidence and mortality in India from 1990 to 2019: a joinpoint and age-period-cohort analysis.
Jha RP; Shri N; Patel P; Dhamnetiya D; Bhattacharyya K; Singh M
J Diabetes Metab Disord; 2021 Dec; 20(2):1725-1740. PubMed ID: 34900822
[TBL] [Abstract][Full Text] [Related]
3. Trends in incidence and mortality of tuberculosis in India over past three decades: a joinpoint and age-period-cohort analysis.
Dhamnetiya D; Patel P; Jha RP; Shri N; Singh M; Bhattacharyya K
BMC Pulm Med; 2021 Nov; 21(1):375. PubMed ID: 34784911
[TBL] [Abstract][Full Text] [Related]
4. Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019.
Golabi P; Paik JM; AlQahtani S; Younossi Y; Tuncer G; Younossi ZM
J Hepatol; 2021 Oct; 75(4):795-809. PubMed ID: 34081959
[TBL] [Abstract][Full Text] [Related]
5. Increasing prevalence of NAFLD/NASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study.
Zhang X; Wu M; Liu Z; Yuan H; Wu X; Shi T; Chen X; Zhang T
BMJ Open; 2021 May; 11(5):e042843. PubMed ID: 33947727
[TBL] [Abstract][Full Text] [Related]
6. Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990-2017: a population-based observational study.
Ge X; Zheng L; Wang M; Du Y; Jiang J
BMJ Open; 2020 Aug; 10(8):e036663. PubMed ID: 32747349
[TBL] [Abstract][Full Text] [Related]
7. Magnitude of Nonalcoholic Fatty Liver Disease: Western Perspective.
Samji NS; Verma R; Satapathy SK
J Clin Exp Hepatol; 2019; 9(4):497-505. PubMed ID: 31516266
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Trends of Liver Cancer Incidence and Mortality in China 1990-2017: A Joinpoint and Age-Period-Cohort Analysis.
Wang F; Mubarik S; Zhang Y; Wang L; Wang Y; Yu C; Li H
Int J Environ Res Public Health; 2019 Aug; 16(16):. PubMed ID: 31408961
[TBL] [Abstract][Full Text] [Related]
9. Recent Epidemiology of Nonalcoholic Fatty Liver Disease.
Murag S; Ahmed A; Kim D
Gut Liver; 2021 Mar; 15(2):206-216. PubMed ID: 32921636
[TBL] [Abstract][Full Text] [Related]
10. Secular trends in the incidence of eating disorders in China from 1990 to 2017: a joinpoint and age-period-cohort analysis.
Wu J; Lin Z; Liu Z; He H; Bai L; Lyu J
Psychol Med; 2022 Apr; 52(5):946-956. PubMed ID: 32744194
[TBL] [Abstract][Full Text] [Related]
11. Trends in the Incidence and Mortality of Diabetes in China from 1990 to 2017: A Joinpoint and Age-Period-Cohort Analysis.
Liu X; Yu C; Wang Y; Bi Y; Liu Y; Zhang ZJ
Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626127
[No Abstract] [Full Text] [Related]
12. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.
Younossi ZM; Blissett D; Blissett R; Henry L; Stepanova M; Younossi Y; Racila A; Hunt S; Beckerman R
Hepatology; 2016 Nov; 64(5):1577-1586. PubMed ID: 27543837
[TBL] [Abstract][Full Text] [Related]
13. Long-term trends in the incidence of endometriosis in China from 1990 to 2019: a joinpoint and age-period-cohort analysis.
Feng J; Zhang S; Chen J; Yang J; Zhu J
Gynecol Endocrinol; 2021 Nov; 37(11):1041-1045. PubMed ID: 34519590
[TBL] [Abstract][Full Text] [Related]
14. A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.
Lazarus JV; Ekstedt M; Marchesini G; Mullen J; Novak K; Pericàs JM; Roel E; Romero-Gómez M; Ratziu V; Tacke F; Cortez-Pinto H; Anstee QM;
J Hepatol; 2020 Jan; 72(1):14-24. PubMed ID: 31518646
[TBL] [Abstract][Full Text] [Related]
15. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
Estes C; Anstee QM; Arias-Loste MT; Bantel H; Bellentani S; Caballeria J; Colombo M; Craxi A; Crespo J; Day CP; Eguchi Y; Geier A; Kondili LA; Kroy DC; Lazarus JV; Loomba R; Manns MP; Marchesini G; Nakajima A; Negro F; Petta S; Ratziu V; Romero-Gomez M; Sanyal A; Schattenberg JM; Tacke F; Tanaka J; Trautwein C; Wei L; Zeuzem S; Razavi H
J Hepatol; 2018 Oct; 69(4):896-904. PubMed ID: 29886156
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.
Sayiner M; Koenig A; Henry L; Younossi ZM
Clin Liver Dis; 2016 May; 20(2):205-14. PubMed ID: 27063264
[TBL] [Abstract][Full Text] [Related]
17. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Younossi ZM; Koenig AB; Abdelatif D; Fazel Y; Henry L; Wymer M
Hepatology; 2016 Jul; 64(1):73-84. PubMed ID: 26707365
[TBL] [Abstract][Full Text] [Related]
18. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.
Estes C; Razavi H; Loomba R; Younossi Z; Sanyal AJ
Hepatology; 2018 Jan; 67(1):123-133. PubMed ID: 28802062
[TBL] [Abstract][Full Text] [Related]
19. Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study.
Swain MG; Ramji A; Patel K; Sebastiani G; Shaheen AA; Tam E; Marotta P; Elkhashab M; Bajaj HS; Estes C; Razavi H
CMAJ Open; 2020; 8(2):E429-E436. PubMed ID: 32518095
[TBL] [Abstract][Full Text] [Related]
20. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
